BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients

被引：0
作者：
H Yazici
O Bitisik
E Akisik
N Cabioglu
P Saip
M Muslumanoglu
G Glendon
E Bengisu
S Ozbilen
M Dincer
S Turkmen
I L Andrulis
N Dalay
H Ozcelik
机构：
[1] Centre for Cancer Genetics,Department of Pathology and Laboratory Medicine
[2] Samuel Lunenfeld Research Institute,Basic Oncology Department
[3] Mount Sinai Hospital,Breast Surgery Department
[4] Istanbul University Oncology Institute,Clinical Oncology Department
[5] Istanbul Medical Faculty,Gynecology Department
[6] Istanbul University Oncology Institute,Department of Biochemistry
[7] Istanbul Medical Faculty,undefined
[8] Istanbul Samatya SSK Training Hospital,undefined
[9] Department of Laboratory Medicine and Pathobiology,undefined
[10] Molecular and Medical Genetics,undefined
[11] University of Toronto,undefined
[12] Cancer Care Ontario,undefined
[13] Toronto,undefined
来源：
British Journal of Cancer | 2000年 / 83卷
关键词：
BRCA1; BRCA2; mutations; PTT; breast and ovarian cancer; Turkish population;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
To date, BRCA1 and BRCA2 mutations in breast and/or ovarian patients have not been characterized in the Turkish population. We investigated the presence of BRCA mutations in 53 individuals with a personal and family history of breast and/or ovarian cancer, and 52 individuals with a personal history of breast cancer diagnosed below age 50 without additional family history. We have identified 11 mutations (nine BRCA1 and two BRCA2) using combined techniques involving protein truncation test, direct sequencing and heteroduplex analysis. We found eight out of 53 patients (15.1%) with a family history to carry BRCA gene mutations (seven BRCA1 and one BRCA2). Of these, four were found in 43 families presenting only breast cancer histories, and four were found in families presenting ovarian cancer with or without breast cancer. We also demonstrated two BRCA1 and one BRCA2 mutations in three out of 52 (5.8%) early-onset breast cancer cases without additional family history. Three of nine BRCA1 and both BRCA2 mutations detected in this study were not reported previously. These mutations may be specific to the Turkish population. The BRCA1 5382insC mutation, specific to Ashkenazi and Russian populations, was found twice in our study group, representing a possible founder mutation in the Turkish population. © 2000 Cancer Research Campaign
引用
收藏
页码：737 / 742
页数：5
相关论文
共 362 条
[1]  
Abeliovich D(1997)The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT inBRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women Am J Hum Genet 60 505-514
[2]  
Kaduri L(1996)A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals Cancer Res 56 3409-3414
[3]  
Lerer I(1996)Mutations and polymorphisms in the familial early-onset breast cancer BRCA1 gene. Breast cancer Information Core Hum Mutat 8 8-18
[4]  
Weinberg N(1997)BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer N Engl J Med 336 1409-1415
[5]  
Amir G(1999)Strong founder effects in BRCA1 mutation carrier breast cancer patients from Latvia Hum Mutat 14 92-701
[6]  
Sagi M(1993)Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families Am J Hum Genet 52 678-695
[7]  
Zlotogora J(1994)Risks of cancer in BRCA1-mutation carriers Lancet 343 692-689
[8]  
Heching N(1998)Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families Am J Hum Genet 62 676-1297
[9]  
Peretz T(1995)Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families Am J Hum Genet 57 1284-1242
[10]  
Berman DB(1997)Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia Am J Hum Genet 60 1239-1078
12345678910